Le mode conseil est activé Arrêter
Pour la navigation rapide entre les blocs

Organisation: Biogen
LEI W8J5WZB5IY3K0NDQT671

Nom de l'organisation
Biogen Inc.
Nom du pays
États-Unis
Pays d'enregistrement
États-Unis
Secteur économique
Production de médicaments et biotechnologies
Dette obligataire
6.567 millions USD

explorer la base de données la plus complète

800 000

obligations globalement

Plus de 400

sources de prix

80 000

actions

9 000

ETF

suivre votre portefeuille de la manière la plus efficace
screener d'obligations
liste de surveillance
Excel ADD-IN
Obtenir l'accès

Dernières données pour

Cotations

Requête envoyé
Accès refusé
Envoyer la requête
Les cotations fournis par les fournisseurs d’information sont de nature indicative

Profile

Biogen Inc. is a global biotechnology company. The Company discovers, develops, manufactures and markets therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. The Company’s products include AVONEX, TYSABRI, FAMPYRA, FUMADERM and RITUXAN.

Récompenses

Actualités

24/04/2024 Biogen: Results Of Operations And Financial Condition, Financial Statements And Exhibits
23/04/2024 S&P Global Ratings affirms Biogen at "BBB+" (Foreign Currency LT credit rating); outlook stable
23/04/2024 S&P Global Ratings affirms Biogen at "BBB+" (Local Currency LT credit rating); outlook stable
05/03/2024 Moody's Investors Service revised outlook on Biogen to stable and affirmed at "Baa2" (LT- local currency) credit rating
13/02/2024 Biogen: Results Of Operations And Financial Condition, Financial Statements And Exhibits
Toutes les actualités de l'organisation

Documents

Etats financiers IFRS / US GAAP

2024
I q ang
2023
I q ang
II q ang
III q ang
IV q ang
2022
I q ang
II q ang
III q ang
IV q ang
2021
I q ang
II q ang
III q ang
IV q ang
2020
I q ang
II q ang
III q ang
IV q ang
2019
I q ang
II q ang
III q ang
IV q ang
2018
I q ang
II q ang
III q ang
IV q ang
2017
I q ang
II q ang
III q ang
IV q ang
2016
I q ang
II q ang
III q ang
IV q ang
2015
I q ang
II q ang
III q ang
IV q ang
2014
IV q ang
Afficher tout Masquer
Il faut s'enregistrer
Envoyer la demande d'accès accès

Actions

Dernières émissions

Montrer tout

Dette obligataire par devise

Montrer tout Cacher

Codes

  • LEI
    W8J5WZB5IY3K0NDQT671
  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • CIK
    0000875045
  • EIN
    33-0112644

Notations de crédit et notations d’ESG

Macroéconomie

Vous devez vous inscrire pour y accéder.